Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size.

Laidlaw TM, Prussin C, Panettieri RA, Lee S, Ferguson BJ, Adappa ND, Lane AP, Palumbo ML, Sullivan M, Archibald D, Dworetzky SI, Hebrank GT, Bozik ME.

Laryngoscope. 2019 Feb;129(2):E61-E66. doi: 10.1002/lary.27564. Epub 2018 Oct 4.

PMID:
30284267
2.

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes.

Panch SR, Bozik ME, Brown T, Makiya M, Prussin C, Archibald DG, Hebrank GT, Sullivan M, Sun X, Wetzler L, Ware J, Fay MP, Dunbar CE, Dworetzky SI, Khoury P, Maric I, Klion AD.

Blood. 2018 Aug 2;132(5):501-509. doi: 10.1182/blood-2018-02-835330. Epub 2018 May 8. Erratum in: Blood. 2018 Sep 27;132(13):1461.

3.

Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).

Khoury P, Akuthota P, Ackerman SJ, Arron JR, Bochner BS, Collins MH, Kahn JE, Fulkerson PC, Gleich GJ, Gopal-Srivastava R, Jacobsen EA, Leiferman KM, Francesca LS, Mathur SK, Minnicozzi M, Prussin C, Rothenberg ME, Roufosse F, Sable K, Simon D, Simon HU, Spencer LA, Steinfeld J, Wardlaw AJ, Wechsler ME, Weller PF, Klion AD.

J Leukoc Biol. 2018 Jul;104(1):69-83. doi: 10.1002/JLB.5MR0118-028R. Epub 2018 Apr 19. Review.

4.

Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease.

Mitson-Salazar A, Prussin C.

Front Med (Lausanne). 2017 Oct 6;4:165. doi: 10.3389/fmed.2017.00165. eCollection 2017. Review.

5.

Rapamycin preferentially inhibits human IL-5+ TH2-cell proliferation via an mTORC1/S6 kinase-1-dependent pathway.

Yin Y, Mitson-Salazar A, Wansley DL, Singh SP, Prussin C.

J Allergy Clin Immunol. 2017 May;139(5):1701-1704.e10. doi: 10.1016/j.jaci.2016.10.029. Epub 2016 Dec 3. No abstract available.

PMID:
27923564
6.

Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in Mastocytosis.

Kim DK, Beaven MA, Kulinski JM, Desai A, Bandara G, Bai Y, Prussin C, Schwartz LB, Komarow H, Metcalfe DD, Olivera A.

PLoS One. 2016 Sep 9;11(9):e0162831. doi: 10.1371/journal.pone.0162831. eCollection 2016.

7.

Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases.

Metcalfe DD, Pawankar R, Ackerman SJ, Akin C, Clayton F, Falcone FH, Gleich GJ, Irani AM, Johansson MW, Klion AD, Leiferman KM, Levi-Schaffer F, Nilsson G, Okayama Y, Prussin C, Schroeder JT, Schwartz LB, Simon HU, Walls AF, Triggiani M.

World Allergy Organ J. 2016 Feb 11;9:7. doi: 10.1186/s40413-016-0094-3. eCollection 2016. Review.

8.

IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3.

Desai A, Jung MY, Olivera A, Gilfillan AM, Prussin C, Kirshenbaum AS, Beaven MA, Metcalfe DD.

J Allergy Clin Immunol. 2016 Jun;137(6):1863-1871.e6. doi: 10.1016/j.jaci.2015.09.059. Epub 2016 Jan 7.

9.

Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function.

Mitson-Salazar A, Yin Y, Wansley DL, Young M, Bolan H, Arceo S, Ho N, Koh C, Milner JD, Stone KD, Wank SA, Prussin C.

J Allergy Clin Immunol. 2016 Mar;137(3):907-18.e9. doi: 10.1016/j.jaci.2015.08.007. Epub 2015 Oct 1.

PMID:
26431580
10.

Detection of Intracellular Cytokines by Flow Cytometry.

Yin Y, Mitson-Salazar A, Prussin C.

Curr Protoc Immunol. 2015 Aug 3;110:6.24.1-6.24.18. doi: 10.1002/0471142735.im0624s110.

PMID:
26237012
11.

Telangiectasia macularis eruptiva perstans or highly vascularized urticaria pigmentosa?

Williams KW, Metcalfe DD, Prussin C, Carter MC, Komarow HD.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):813-5. doi: 10.1016/j.jaip.2014.07.002. Epub 2014 Aug 29. No abstract available.

12.

Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins.

Makiya MA, Herrick JA, Khoury P, Prussin CP, Nutman TB, Klion AD.

J Immunol Methods. 2014 Sep;411:11-22. doi: 10.1016/j.jim.2014.05.020. Epub 2014 Jun 8.

13.

Eosinophilic gastroenteritis and related eosinophilic disorders.

Prussin C.

Gastroenterol Clin North Am. 2014 Jun;43(2):317-27. doi: 10.1016/j.gtc.2014.02.013.

14.
15.

Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome.

Klion AD, Mejia R, Cowen EW, Dowdell KC, Dunleavy K, Fahle GA, Holland-Thomas N, Maric I, Pittaluga S, Raffeld M, Santos C, Stetler-Stevenson M, Krogmann T, Shatzer AN, Turk SP, Yin Y, Xi L, Prussin C, Cohen JI.

Blood. 2013 Mar 21;121(12):2364-6. doi: 10.1182/blood-2012-12-472720. No abstract available.

16.

Interleukin-5+ super-effector Th2 cells as targets for immunotherapy and drug discovery.

Prussin C.

Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess. 2013;97:124-7. No abstract available.

PMID:
24912325
17.

Novel targeted therapies for eosinophilic disorders.

Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, Prussin C, Renzi P, Rothenberg ME, Roufosse F, Simon D, Simon HU, Wardlaw A, Weller PF, Klion AD.

J Allergy Clin Immunol. 2012 Sep;130(3):563-71. doi: 10.1016/j.jaci.2012.07.027. Review.

18.

CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome.

Fan X, Upadhyaya B, Wu L, Koh C, Santín-Durán M, Pittaluga S, Uzel G, Kleiner D, Williams E, Ma CA, Bodansky A, Oliveira JB, Edmonds P, Hornung R, Wong DW, Fayer R, Fleisher T, Heller T, Prussin C, Jain A.

Clin Immunol. 2012 May;143(2):152-61. doi: 10.1016/j.clim.2012.01.014. Epub 2012 Feb 7.

19.

Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells.

Upadhyaya B, Yin Y, Hill BJ, Douek DC, Prussin C.

J Immunol. 2011 Sep 15;187(6):3111-20. doi: 10.4049/jimmunol.1101283. Epub 2011 Aug 17.

20.

Effect of anti-IgE therapy on food allergen specific T cell responses in eosinophil associated gastrointestinal disorders.

Foster B, Foroughi S, Yin Y, Prussin C.

Clin Mol Allergy. 2011 Apr 28;9(1):7. doi: 10.1186/1476-7961-9-7.

21.

T(H)2 heterogeneity: Does function follow form?

Prussin C, Yin Y, Upadhyaya B.

J Allergy Clin Immunol. 2010 Dec;126(6):1094-8. doi: 10.1016/j.jaci.2010.08.031. Epub 2010 Oct 15. Review.

22.

IgE, mast cells, basophils, and eosinophils.

Stone KD, Prussin C, Metcalfe DD.

J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S73-80. doi: 10.1016/j.jaci.2009.11.017. Review.

23.

Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses.

Prussin C, Lee J, Foster B.

J Allergy Clin Immunol. 2009 Dec;124(6):1326-32.e6. doi: 10.1016/j.jaci.2009.09.048.

24.

Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo.

Bonville CA, Percopo CM, Dyer KD, Gao J, Prussin C, Foster B, Rosenberg HF, Domachowske JB.

BMC Immunol. 2009 Mar 19;10:14. doi: 10.1186/1471-2172-10-14.

25.

Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases.

Stone KD, Prussin C.

Clin Exp Allergy. 2008 Dec;38(12):1858-65. doi: 10.1111/j.1365-2222.2008.03122.x. Review.

26.

Detection of intracellular cytokines by flow cytometry.

Foster B, Prussin C, Liu F, Whitmire JK, Whitton JL.

Curr Protoc Immunol. 2007 Aug;Chapter 6:Unit 6.24. doi: 10.1002/0471142735.im0624s78.

PMID:
18432993
27.

Anti-IgE treatment of eosinophil-associated gastrointestinal disorders.

Foroughi S, Foster B, Kim N, Bernardino LB, Scott LM, Hamilton RG, Metcalfe DD, Mannon PJ, Prussin C.

J Allergy Clin Immunol. 2007 Sep;120(3):594-601.

28.

CD2 identifies a monocyte subpopulation with immunoglobulin E-dependent, high-level expression of Fc epsilon RI.

Cheng YX, Foster B, Holland SM, Klion AD, Nutman TB, Casale TB, Metcalfe DD, Prussin C.

Clin Exp Allergy. 2006 Nov;36(11):1436-45.

29.

Abnormal differentiation of memory T cells in systemic lupus erythematosus.

Fritsch RD, Shen X, Illei GG, Yarboro CH, Prussin C, Hathcock KS, Hodes RJ, Lipsky PE.

Arthritis Rheum. 2006 Jul;54(7):2184-97.

30.

5. IgE, mast cells, basophils, and eosinophils.

Prussin C, Metcalfe DD.

J Allergy Clin Immunol. 2006 Feb;117(2 Suppl Mini-Primer):S450-6. Review.

PMID:
16455345
31.

Inflammatory responses to pneumovirus infection in IFN-alpha beta R gene-deleted mice.

Garvey TL, Dyer KD, Ellis JA, Bonville CA, Foster B, Prussin C, Easton AJ, Domachowske JB, Rosenberg HF.

J Immunol. 2005 Oct 1;175(7):4735-44.

32.

Clinical management of eosinophilic gastrointestinal disorders.

Foroughi S, Prussin C.

Curr Allergy Asthma Rep. 2005 Jul;5(4):259-61. Review. No abstract available.

PMID:
15967064
33.

Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.

Kim YJ, Prussin C, Martin B, Law MA, Haverty TP, Nutman TB, Klion AD.

J Allergy Clin Immunol. 2004 Dec;114(6):1449-55.

PMID:
15577851
34.

Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.

Lin H, Boesel KM, Griffith DT, Prussin C, Foster B, Romero FA, Townley R, Casale TB.

J Allergy Clin Immunol. 2004 Feb;113(2):297-302.

PMID:
14767445
35.

Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.

Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB.

J Allergy Clin Immunol. 2003 Dec;112(6):1147-54.

PMID:
14657874
36.

Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma.

Foster B, Metcalfe DD, Prussin C.

J Allergy Clin Immunol. 2003 Dec;112(6):1132-8.

PMID:
14657872
37.

4. IgE, mast cells, basophils, and eosinophils.

Prussin C, Metcalfe DD.

J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S486-94. Review. Erratum in: J Allergy Clin Immunol. 2003 Aug;112(2):267.

PMID:
12592295
38.

IgE(+), Kit(-), I-A/I-E(-) myeloid cells are the initial source of Il-4 after antigen challenge in a mouse model of allergic pulmonary inflammation.

Luccioli S, Brody DT, Hasan S, Keane-Myers A, Prussin C, Metcalfe DD.

J Allergy Clin Immunol. 2002 Jul;110(1):117-24.

PMID:
12110830
39.

Chemical constituents of diesel exhaust particles induce IL-4 production and histamine release by human basophils.

Devouassoux G, Saxon A, Metcalfe DD, Prussin C, Colomb MG, Brambilla C, Diaz-Sanchez D.

J Allergy Clin Immunol. 2002 May;109(5):847-53.

PMID:
11994710
40.

Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils.

Foster B, Schwartz LB, Devouassoux G, Metcalfe DD, Prussin C.

J Allergy Clin Immunol. 2002 Feb;109(2):287-93.

PMID:
11842299
41.

Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge.

Hagaman DD, Okayama Y, D'Ambrosio C, Prussin C, Gilfillan AM, Metcalfe DD.

Am J Respir Cell Mol Biol. 2001 Dec;25(6):685-91.

PMID:
11726393
42.

IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis.

McInnes IB, Illei GG, Danning CL, Yarboro CH, Crane M, Kuroiwa T, Schlimgen R, Lee E, Foster B, Flemming D, Prussin C, Fleisher TA, Boumpas DT.

J Immunol. 2001 Oct 1;167(7):4075-82.

43.

Update on the management of asthma.

Prussin C, Metcalfe DD.

Adv Intern Med. 2001;46:31-50. Review. No abstract available.

PMID:
11147258
44.
45.
46.

Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.

Gea-Banacloche JC, Migueles SA, Martino L, Shupert WL, McNeil AC, Sabbaghian MS, Ehler L, Prussin C, Stevens R, Lambert L, Altman J, Hallahan CW, de Quiros JC, Connors M.

J Immunol. 2000 Jul 15;165(2):1082-92.

47.

Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells.

Gurunathan S, Stobie L, Prussin C, Sacks DL, Glaichenhaus N, Iwasaki A, Fowell DJ, Locksley RM, Chang JT, Wu CY, Seder RA.

J Immunol. 2000 Jul 15;165(2):915-24. Erratum in: J Immunol 2000 Sep 15;165(6):following 3526.

48.

Frequency and characterization of antigen-specific IL-4- and IL-13- producing basophils and T cells in peripheral blood of healthy and asthmatic subjects.

Devouassoux G, Foster B, Scott LM, Metcalfe DD, Prussin C.

J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):811-9.

PMID:
10518826
49.

Eotaxin potentiates antigen-dependent basophil IL-4 production.

Devouassoux G, Metcalfe DD, Prussin C.

J Immunol. 1999 Sep 1;163(5):2877-82.

50.

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection.

Gurunathan S, Prussin C, Sacks DL, Seder RA.

Nat Med. 1998 Dec;4(12):1409-15.

PMID:
9846579

Supplemental Content

Loading ...
Support Center